2002
DOI: 10.1590/s0074-02762002000600030
|View full text |Cite
|
Sign up to set email alerts
|

Immunogenicity test of tetanus component in adsorbed vaccines by toxin binding inhibition test

Abstract: Samples from 20 lots of diphtheria-tetanus (adult use dT)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
4
0

Year Published

2006
2006
2021
2021

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 10 publications
(4 citation statements)
references
References 16 publications
0
4
0
Order By: Relevance
“…The antibody response against Pf MSP-3 recombinant protein and Influenza vaccine were determinate by conventional Enzyme-Linked immunosorbent Assay—ELISA 9 , 10 , and the antibody response against dT vaccine was determined by Toxin Binding Inhibition—ToBI 26 .…”
Section: Methodsmentioning
confidence: 99%
“…The antibody response against Pf MSP-3 recombinant protein and Influenza vaccine were determinate by conventional Enzyme-Linked immunosorbent Assay—ELISA 9 , 10 , and the antibody response against dT vaccine was determined by Toxin Binding Inhibition—ToBI 26 .…”
Section: Methodsmentioning
confidence: 99%
“…A new immunoenzymatic test, ViBI, was developed based on our previous work regarding the detection of neutralizing antibodies against tetanus and diphtheria toxins [ 43 ]. Plates were coated with 100 µL of 1 μg/mL 2D12 monoclonal antibody (Bio-Rad, Hercules, CA, USA) in carbonate-bicarbonate buffer pH 9.6 and incubated overnight at 4 °C.…”
Section: Methodsmentioning
confidence: 99%
“…In recent years serological models have been developed which can be used as a replacement for lethal challenge procedures in potency testing of Diphtheria and Tetanus Toxoid vaccines (3, 4). Russell and Buch (1959) have introduced the concept of three Rs: replacement, reduction and refinement as a starting-point for ethical behavior concerning experimental animals.…”
mentioning
confidence: 99%
“…Nevertheless, it still remains the gold standard to evaluate the potency of the pertussis component from diphtheria-tetanus toxoid and whole cell pertussis vaccine lots (DTPw). In recent years, serological procedures have been developed to permit the replacement for lethal challenge tests, like the MPT, in the potency control of diphtheria and tetanus components of the DTP vaccine (1, 3, 4). In 1994, van der Ark and collaborators developed an enzyme-linked immunosorbent assay, the Pertussis Serology Potency Test (PSPT), as an unconventional method for pertussis potency control.…”
mentioning
confidence: 99%